Klotho Neurosciences, Inc. KLTO
Mar 16, 2026, 3:59 PM EDT
52-week range unavailable
- YTD
- +31.83%
- 1 year
- +34.72%
- Market cap
- 9.86M
- Shares out
- 23.26M
- YTD return
- +31.83%
- 1-year return
- +34.72%
- Volume
- 95.00K
- Open
- 0.406
- Previous close
- 0.381
- Day's range
- 0.37 – 0.41
- Beta
- 0.06
Key statistics
- Enterprise value
- 10.29M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 424.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -168.17K
- Total cash
- 845.34K
- Total debt
- 3.90M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.45094
- 200-day average
- 3.47
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- klothoneuro.com
News
Klotho Neurosciences (NASDAQ:KLTO) and Xenetic Biosciences (NASDAQ:XBIO) Head to Head Contrast 
Citius Pharmaceuticals (NASDAQ:CTXR) and Klotho Neurosciences (NASDAQ:KLTO) Head-To-Head Comparison 
Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML 
Klotho Neurosciences Announces Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML Effective March 12, 2026 
KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR 
12 Health Care Stocks Moving In Friday's After-Market Session 
12 Health Care Stocks Moving In Friday's Intraday Session - 12 Health Care Stocks Moving In Thursday's Intraday Session
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI) - 12 Health Care Stocks Moving In Monday's After-Market Session
Your note
Sign in to keep a note on KLTO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHARDAN MONTEREY INVESTMENTS LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 1, 2024 | 1,284,360 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Meteora Capital, LLC | 2.51% | 533,951 | 226.40K | Sep 29, 2024 |
| Morgan Stanley | 0.47% | 100,000 | 42.40K | Sep 29, 2024 |
| MMCAP International, Inc. SPC | 0.38% | 80,000 | 33.92K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.30% | 63,234 | 26.81K | Sep 29, 2024 |
| UBS Group AG | 0.07% | 15,306 | 6.49K | Sep 29, 2024 |
| Gabelli & Co. Investment Advisers, Inc. | 0.05% | 10,000 | 4.24K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.23% | 47,923 | 20.32K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 14,768 | 6.26K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 12,306 | 5.22K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 3,048 | 1.29K | Oct 30, 2024 |